Orforglipron is currently being evaluated for safety in the treatment of weight loss and type 2 diabetes through clinical trials
Important Notices:
This product is sold for scientific research purposes only.
Product is provided as a white tablet in a sealed bottle.
Bottle appearance may vary from pictured.
Orforglipron is an investigational once-daily oral GLP-1. It mimics the GLP-1 hormone, which helps control appetite, increase insulin release, and reduce glucagon, leading to lower blood sugar and reduced food intake.